Sort
38,696 grants matching “als”
Emergent Social Environments As Predictors of Recovery Resident Outcomes
$610,905Leonard A Jason · De Paul University · R01 · FY2018 · AA
Impact of harm reduction care in HIV clinical settings on stigma and health outcomes for PLWH who use drugs
$610,732Mary Elizabeth Hawk · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · DA
The Frontal Lobe and Basal Ganglia in Behavioral Inhibition and Selection
$610,672Steven P Wise · National Institute Of Mental Health · Z01 · FY2007 · MH
IL-4-activated macrophages: Contribution to allergic lung inflammation linked to viral infection
$610,630Achsah D. Keegan · University Of Maryland Baltimore · R01 · FY2020 · AI
IL-4-activated macrophages: Contribution to allergic lung inflammation linked to viral infection
$610,630Achsah D. Keegan · University Of Maryland Baltimore · R01 · FY2019 · AI
IL-4-activated macrophages: Contribution to allergic lung inflammation linked to viral infection
$610,630Achsah D. Keegan · University Of Maryland Baltimore · R01 · FY2023 · AI
IL-4-activated macrophages: Contribution to allergic lung inflammation linked to viral infection
$610,630Achsah D. Keegan · University Of Maryland Baltimore · R01 · FY2022 · AI
IL-4-activated macrophages: Contribution to allergic lung inflammation linked to viral infection
$610,630Achsah D. Keegan · University Of Maryland Baltimore · R01 · FY2021 · AI
PET Imaging of neurochemical transmission in cocaine use disorders
$610,313Rajesh Narendran · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · DA
Influence of Post-transcriptional Gene Regulation on Cell Senescence and Aging
$610,189Myriam Gorospe · National Institute On Aging · ZIA · FY2014 · AG
Contribution of neuroplasticity in the rostral ventrolateral medulla to physical inactivity-related cardiovascular disease
$610,085Patrick J Mueller · Wayne State University · R01 · FY2024 · HL
Efficacy of Family Programs for Improving Child and Family Health and Development.
$610,040Julia Braungart-Rieker · University Of Notre Dame · R01 · FY2019 · HD
Circular RNAs and their interactions with RNA-binding proteins to modulate AD-related neuropathology
$610,029Xiaoling Zhang · Boston University Medical Campus · U01 · FY2024 · AG
Mechanisms of Asthma Pathogenesis and Treatment
$610,017Stewart Levine · National Heart, Lung, And Blood Institute · Z01 · FY2008 · HL
Understanding tumor addiction to TRK fusions and sensitivity to TRK inhibition
$609,943Maurizio Scaltriti · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
CRCNS: Data-efficient natural image reconstruction to advance visual neuroscience
$609,876Thomas C Sprague · University Of California Santa Barbara · R01 · FY2025 · EY
Molecular Profiling of Pancreatic Cancer
$609,814Syed Hussain · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Exercise Adhrence Among Older Adults with Osteoarthritis
$609,798Susan L Hughes · University Of Illinois At Chicago · R01 · FY2006 · AG
FUNCTION OF PROSTAGLANDIN RECEPTORS IN MODELS OF ALS
$609,744The Johns Hopkins University · · FY2008 · Department of Defense
Mechanisms of Oligodendrocyte Activity on Chronic Brain Implants and Recording Performance
$609,737Takashi Daniel Yoshida Kozai · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · NS
Mechanisms of Oligodendrocyte Activity on Chronic Brain Implants and Recording Performance
$609,737Takashi Daniel Yoshida Kozai · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · NS
Novel Protein Aggregation Inhibitors and Upper Motor Neuron Stabilizers for ALS and other Neurodegenerative Diseases
$609,584Pembe Hande Ozdinler · Northwestern University At Chicago · R01 · FY2022 · AG
Designing a Plan of Action for Better Access and Quality of Surgery for African-Americans with Gastrointestinal Cancers in the Deep South
$609,503Maria Pisu · University Of Alabama At Birmingham · R01 · FY2022 · MD
Neurobiology and Treatment of Reading Disability in NF1
$609,406Laurie E Cutting · Vanderbilt University · R01 · FY2022 · HD
Assess the Effects of ETS on Neurodevelopment
$609,396Virginia A Rauh · Columbia University Health Sciences · R01 · FY2013 · DA